+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Infection Prevention Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805790
The global infection prevention devices market value was USD 18.3 billion in 2022, driven by the increasing awareness of HAIs and the need for effective infection control measures across the globe. The market size is anticipated to grow at a CAGR of 5.5% during the forecast period of 2023-2031 to achieve a value of USD 29.6 billion by 2031.


Infection prevention devices play a crucial role in reducing the risk of healthcare-associated infections (HAIs) and improving patient safety. These devices are designed to prevent the transmission of pathogens in healthcare settings by creating barriers, promoting proper hygiene practices, and implementing infection control measures.

The market for infection prevention devices encompasses a wide range of products, including personal protective equipment (PPE), sterilization and disinfection equipment, wound care products, and environmental cleaning devices. These devices are used in hospitals, clinics, ambulatory surgical centers, long-term care facilities, and other healthcare settings.

The primary objective of infection prevention devices is to minimize the spread of infectious agents, such as bacteria, viruses, and fungi, among patients, healthcare workers, and visitors. They include items like gloves, masks, gowns, respirators, hand hygiene products, surface disinfectants, sterilizers, and wound dressings
The demand for infection prevention devices is driven by the increasing awareness of HAIs and the need for effective infection control measures. Healthcare facilities and professionals are increasingly focused on implementing stringent infection prevention protocols to reduce the risk of infections and protect patients.

Key Trends in the Infection Prevention Devices Market

Some key trends involved in the infection prevention devices market are as follows:
  • Increasing emphasis on hand hygiene: Hand hygiene is a critical aspect of infection prevention, and there is a growing focus on promoting proper hand hygiene practices among healthcare workers. This trend includes the use of innovative hand hygiene products, such as touchless hand sanitizers and hand hygiene monitoring systems, to improve compliance and reduce the risk of infection transmission
  • Growing demand for antimicrobial-coated devices: The use of antimicrobial coatings on infection prevention devices is gaining traction. These coatings help inhibit the growth of microorganisms on the device surfaces, reducing the risk of contamination and infection. Antimicrobial-coated catheters, wound dressings, and surfaces in healthcare settings are becoming increasingly popular to enhance infection prevention measures
  • Adoption of advanced sterilization technologies: Traditional sterilization methods are being complemented by advanced sterilization technologies to ensure effective disinfection of medical instruments and devices. Technologies such as hydrogen peroxide vapor, ozone sterilization, and plasma sterilization offer improved efficacy, shorter processing times, and compatibility with sensitive equipment
  • Integration of smart technology: The integration of smart technology in infection prevention devices is becoming more prevalent. This includes the use of connected devices, sensors, and data analytics to monitor and track compliance with infection prevention protocols, optimize disinfection processes, and provide real-time alerts and notifications

Infection Prevention Devices Market Segmentations

Market Breakup by Product

  • Infection Prevention Supplies
  • Infection Prevention Services
  • Infection Prevention Equipment

Market by End User

  • Hospitals
  • Lifescience Industries
  • Clinical Laboratories
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Infection Prevention Devices Market Scenario

The market for infection prevention devices is witnessing significant growth due to the increasing focus on patient safety, rising awareness of healthcare-associated infections (HAIs), and the implementation of stringent infection control protocols in healthcare settings. Infection prevention devices play a vital role in preventing the transmission of pathogens and reducing the risk of HAIs among patients, healthcare workers, and visitors.

The market offers a wide range of infection prevention devices, including personal protective equipment (PPE) such as gloves, masks, gowns, and respirators, as well as disinfection equipment, sterilization systems, wound care products, and environmental cleaning devices. These devices are essential in maintaining a clean and safe healthcare environment, preventing the spread of infectious agents, and minimizing the risk of cross-contamination.

Factors driving the growth of the market include the increasing prevalence of HAIs, the growing awareness of infection control measures, and the rise in healthcare spending. Healthcare facilities and professionals are recognizing the importance of adopting effective infection prevention strategies to improve patient outcomes and reduce healthcare costs associated with treating HAIs.

The market is also influenced by government initiatives and regulations promoting infection control practices, as well as the implementation of guidelines and standards by healthcare organizations. Additionally, technological advancements in infection prevention devices, such as the development of advanced disinfection systems and innovative PPE materials, are contributing to market growth.

Infection Prevention Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medline Industries, LP
  • Cardinal Health
  • Paul Hartmann AG
  • Mölnlycke Health Care AB
  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Group
  • Becton, Dickinson and Company
  • Hollister Incorporated
  • Medical Devices Business Services, Inc. (Johnson & Johnson)
  • Getinge AB
  • BD

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Infection Prevention Devices Market Overview
3.1 Global Infection Prevention Devices Market Historical Value (2016-2022)
3.2 Global Infection Prevention Devices Market Forecast Value (2023-2031)
4 Global Infection Prevention Devices Market Landscape
4.1 Global Infection Prevention Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Infection Prevention Devices Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by End User
5 Global Infection Prevention Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Infection Prevention Devices Market Segmentation
6.1 Global Infection Prevention Devices Market by Product
6.1.1 Market Overview
6.1.2 Infection Prevention Supplies
6.1.3 Infection Prevention Services
6.1.4 Infection Prevention Equipment
6.2 Global Infection Prevention Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Lifescience Industries
6.2.4 Clinical Laboratories
6.2.5 Others
6.3 Global Infection Prevention Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Infection Prevention Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Infection Prevention Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Infection Prevention Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Infection Prevention Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Infection Prevention Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Medline Industries, LP
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cardinal Health
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Paul Hartmann AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Mölnlycke Health Care AB
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 3M Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Coloplast Group
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Becton, Dickinson and Company
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hollister Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medical Devices Business Services, Inc. (Johnson & Johnson)
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Getinge AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BD
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Infection Prevention Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medline Industries
  • LP
  • Cardinal Health
  • Paul Hartmann AG
  • Mölnlycke Health Care AB
  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Group
  • Becton
  • Dickinson and Company
  • Hollister Incorporated
  • Medical Devices Business Services Inc. (Johnson & Johnson)
  • Getinge AB
  • BD



Table Information